Updated: Lonza sets sights on expansion, buying Novartis facility; IQVIA leads $14 million Series B funding round
→ Lonza Pharma & Biotech is expanding, buying up a Swiss facility Novartis has been using to produce drug vials and plugging …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.